Clostridium difficile Infection and Fecal Microbiota Transplant

Por Liubakka, Alyssa, Vaughn, Byron P.
Publicado no AACN Adv Crit Care (2016)

Novel treatment options for ulcerative colitis

Por Vaughn, Byron P, Moss, Alan C
Publicado em 2013

Optimal delivery of follow-up care after surgery for Crohn’s disease: current perspectives

Por Campbell, James P, Vaughn, Byron P
Publicado no Clin Exp Gastroenterol (2016)

Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease

Por Weingarden, Alexa R., Vaughn, Byron P.
Publicado no Gut Microbes (2017)

The Role of Mucosal Healing in the Treatment of Patients with Inflammatory Bowel Disease

Por Vaughn, Byron P., Shah, Sveta, Cheifetz, Adam S.
Publicado em 2014

Biologic Concentration Testing in Inflammatory Bowel Disease

Por Vaughn, Byron P., Sandborn, William J., Cheifetz, Adam S.
Publicado no Inflamm Bowel Dis (2015)

Intussusception after Routine Colonoscopy: A Rare Complication

Por Min, Michael X., Sklow, Bradford, Vaughn, Byron P.
Publicado no ACG Case Rep J (2017)

Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease

Por Newman, Krista M., Rank, Kevin M., Vaughn, Byron P., Khoruts, Alexander
Publicado no Gut Microbes (2017)

Acid-suppressive Medication Use and the Risk for Nosocomial Gastrointestinal Bleeding

Por Herzig, Shoshana J., Vaughn, Byron P., Howell, Michael D., Ngo, Long H., Marcantonio, Edward R.
Publicado em 2011

Improved Long-Term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab

Por Papamichael, Konstantinos, Chachu, Karen A., Vajravelu, Ravy, Vaughn, Byron P., Ni, Josephine, Osterman, Mark T., Cheifetz, Adam S.
Publicado no Clin Gastroenterol Hepatol (2017)

Proactive Therapeutic Concentration Monitoring of Infliximab May Improve Outcomes for Patients with Inflammatory Bowel Disease: Results from a Pilot Observational Study

Por Vaughn, Byron P., Martinez-Vazquez, Manuel, Patwardhan, Vilas R., Moss, Alan C., Sandborn, William J., Cheifetz, Adam S.
Publicado no Inflamm Bowel Dis (2014)

Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

Por Khoruts, Alexander, Rank, Kevin M., Newman, Krista M., Viskocil, Kimberly, Vaughn, Byron P., Hamilton, Matthew J., Sadowsky, Michael J.
Publicado no Clin Gastroenterol Hepatol (2016)

Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota

Por Staley, Christopher, Vaughn, Byron P., Graiziger, Carolyn T., Singroy, Stephanie, Hamilton, Matthew J., Yao, Dan, Chen, Chi, Khoruts, Alexander, Sadowsky, Michael J.
Publicado no Gut Microbes (2017)

Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study

Por Staley, Christopher, Hamilton, Matthew J., Vaughn, Byron P., Graiziger, Carolyn T., Newman, Krista M., Kabage, Amanda J., Sadowsky, Michael J., Khoruts, Alexander
Publicado no Am J Gastroenterol (2017)

Volunteer patients and small groups contribute to abdominal examination’s success

Por Shields, Helen M, Fernandez-Becker, Nielsen Q, Flier, Sarah N, Vaughn, Byron P, Tukey, Melissa H, Pelletier, Stephen R, Horst, Douglas A
Publicado no Adv Med Educ Pract (2017)

Increased Intestinal Microbial Diversity following Fecal Microbiota Transplant for Active Crohn’s Disease

Por Vaughn, Byron P, Vatanen, Tommi, Allegretti, Jessica R, Bai, Aiping, Xavier, Ramnik J, Korzenik, Joshua, Gevers, Dirk, Ting, Amanda, Robson, Simon C, Moss, Alan C
Publicado no Inflamm Bowel Dis (2016)